Egeberg discusses promising new treatments and insights from recent clinical trials, highlighting significant advancements in chronic hand eczema and atopic dermatitis care presented at the EADV 2024.
The approval of Galderma’s Restylane Eyelight was one of Martin’s top highlights of 2023.
More than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
J.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
Todd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.
The FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
The hair guru explains how he opened up the first dermatology practice dedicated to hair, pearls from his session, innovative therapies, and research he has recently submitted.
How will new federal law affect lives and wallets of physicians?
In 2023 as many as 11 biosimilars to Humira are headed for the US market.
Paller discusses her SPD 2024 lecture, "Updates from ISSVA, ESPD, and SID: What You Missed that Could Change Your Practice."
Delgocitinib is first-in-class pan-Janus kinase inhibitor.
Kirby presented at both Fall Clinical and the Inflammatory Disease Summit in Las Vegas.
The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.
Ami Greene, MD, discusses her beginner and intermediate SDPA fall conference sessions on dermoscopy.
Three distinct congresses known as RAVE (Revolutionizing Atopic Dermatitis, Alopecia Areata, and Vitiligo) will be held June 8-10, in Chicago, Illinois.
By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
Joel Schlessinger, MD, shares his atopic dermatitis insights.
The clinical and histologic subtypes encompassed by granulomatous dermatitis include palisaded neutrophilic granulomatous dermatitis and interstitial granulomatous dermatitis. This review compares the features of each cutaneous eruption.
From explaining how medications work and should be taken to reviewing potential adverse effects and financial details, pharmacists are crucial resources for patients undergoing treatment for skin cancer.
Medical networks and smaller practices alike are facing spiraling inflation costs and staffing shortfalls due to waves of COVID cases that are impacting physicians, staff, and management.
Hyaluronic acid fillers and biostimulators were a couple of Prather's recent favorite aesthetic advancements.
An expert in dermatology shares her thoughts at AAD on the sun protection needs in her patients with skin of color; highlighting the role of the Fitzpatrick skin type scale and compounds such as vitamin E and antioxidants.
Closing out their discussion on the management of plaque psoriasis, panelists share their excitement for future directions in care.